Evidence map›Paper›PMID 20670380›Full record

ArticleJournal of the American Geriatrics Society2010

Neuroimaging in the clinical diagnosis of dementia: observations from a memory disorders clinic.

Paul R Borghesani, Shaune M DeMers, Vivek Manchanda, Sumit Pruthi, David H Lewis, Soo Borson

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Neurosyphilis manifesting with rapidly progressive dementia: report of three cases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2013
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Paul R BorghesaniDepartment of Psychiatry and Behavioral Sciences, University of Washington Medical Center, Seattle, Washington, USA. paulrb@uw.edu
Shaune M DeMers
Vivek Manchanda
Sumit Pruthi
David H Lewis
Soo Borson
University of Washington Medical Center · USImaging Center · USSeattle Children's Hospital · US

Funding

THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI KEENE, CHRISTOPHER DIRK · 1985 to 2019
$57.2M
Institute for Translational Health Science (KL2)KL2RR025015 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$9.3M
NCRR NIH HHS 5KL2RR025015-02NCRR NIH HHS KL2 RR025015NIA NIH HHS P50 AG005136NIA NIH HHS P50 AG 05136
6 · The paper itself

Abstract

objectivesTo determine how often neuroimaging confirms, clarifies, or contradicts initial diagnoses of late-life cognitive disorders.

designRetrospective case review.

settingOutpatient clinic specializing in memory disorders.

participantsOne hundred ninety-three consecutively referred cognitively impaired patients. MEASUREMENTS: Diagnoses using research criteria were developed for each patient at the first visit and ranged from cognitive impairment without dementia to dementias of single, complex, or indeterminate etiology. Structural (noncontrast magnetic resonance imaging) and perfusion (technetium-99m ethyl cysteine dimer single photon emission computed tomography) images were categorized together as normal, suggestive of specific diseases, or abnormal/not diagnostic.

resultsWhen a single neurodegenerative disease was suspected clinically (n=94), imaging confirmed the diagnosis in 50, contradicted the diagnosis in 32, and was abnormal/not diagnostic in 12. When more than one neurodegenerative etiology was clinically suspected (n=21), imaging assigned a single diagnosis in 13 and only cerebrovascular disease in one and was abnormal/not diagnostic in seven. In dementia not otherwise specified (NOS) (n=33), imaging suggested a specific etiology in 23 and was abnormal/not diagnostic in 10. Abnormal/not diagnostic images were more common in cognitive disorder NOS (n=25, 68%) than in other clinical groups (22%, chi-square=22.8 P<.001). Neuroimaging indicators of cerebrovascular disease were common (60% prevalence) but not predicted by the presence of vascular risk factors alone.

conclusionOverall, neuroimaging confirmed, clarified, or contradicted the initial clinical diagnosis in more than 80% of patients, whereas fewer than 20% had abnormal/not diagnostic patterns. Imaging suggested a complex dementia etiology in 21% of cases clinically thought to be caused by a single process, whereas 46% of complex clinical differential diagnoses appeared to reflect a single causal pattern. Further work is needed to determine whether refinement of clinical diagnoses using specialized neuroimaging improves clinical decision-making and patient outcomes.

Indexed as

Magnetic Resonance ImagingTomography, Emission-Computed, Single-PhotonAgedBrainCerebrovascular DisordersCognition DisordersCysteineDementiaHumansLewy BodiesOximesRadiopharmaceuticalsRetrospective StudiesTechnetiumCysteineethyl cysteinehexamethylpropyleneamine oximeOximesRadiopharmaceuticalsTechnetium

Identifiers

PMID20670380
PMCPMC2955194
OpenAlexW1522658556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.